The emergence and implications of metallo-beta-lactamases in Gram-negative bacteria

T R Walsh1

  • 1Department of Pathology and Microbiology, School of Medical Sciences, University of Bristol, Bristol, UK. t.r.walsh@bristol.ac.uk

Insights

Metallo-beta-lactamase (MBL) genes are increasing Gram-negative antibiotic resistance, complicating treatment for infections like Pseudomonas and Acinetobacter. New antimicrobial agents are urgently needed to combat these resistant bacteria.

Area of Science:

  • Microbiology
  • Molecular Biology
  • Infectious Diseases

Background:

  • Rising Gram-negative antibiotic resistance poses a significant global health threat.
  • Limited new antimicrobial agents are effective against key resistant pathogens like Pseudomonas and Acinetobacter.
  • Metallo-beta-lactamase (MBL) genes confer broad-spectrum resistance to beta-lactam antibiotics, which cannot be inhibited by existing drugs.

Purpose of the Study:

  • To highlight the growing threat of metallo-beta-lactamase (MBL) genes in Gram-negative bacteria.
  • To emphasize the co-resistance patterns associated with MBL genes and their impact on treatment options.
  • To underscore the urgent need for novel antimicrobial compounds against pan-resistant Gram-negative bacteria.

Main Methods:

  • Review of current literature on antibiotic resistance mechanisms, focusing on MBL genes.
  • Analysis of gene mobility, dissemination pathways, and associated resistance patterns.
  • Identification of knowledge gaps in understanding bacterial fitness, acquisition, and host dependency related to resistance.

Main Results:

  • MBL genes, such as blaVIM-2, are rapidly disseminating globally, often linked with aminoglycoside resistance genes.
  • These mobile genetic elements, including integrons and transposons, facilitate the spread of resistance.
  • International travel and bacterial mobility are key factors in the global ascendancy of MBL genes.

Conclusions:

  • The increasing prevalence of MBL genes and co-resistance presents a critical challenge for effective antimicrobial therapy.
  • Further research into bacterial resistance mechanisms and host-pathogen interactions is essential.
  • Urgent development of novel antimicrobial agents by both government and industry is required to address the growing problem of pan-resistant Gram-negative bacteria.

Related Concept Videos

Bacterial Signaling01:30

Bacterial Signaling

Bacterial signaling can occur within bacteria (intracellular) or between bacteria (intercellular). At times, a group of bacteria behaves like a community. To achieve this, they engage in quorum sensing, the perception of higher cell density that causes changes in gene expression. Quorum sensing involves both extracellular and intracellular signaling. The signaling cascade starts with a molecule called an autoinducer (AI). Individual bacteria produce AIs that move out of the bacterial cell...
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
Rapid Identification of Pathogens01:25

Rapid Identification of Pathogens

MALDI-TOF MS has transformed clinical microbiology by offering a rapid and reliable method for pathogen identification. The traditional approach to microbial identification typically involves time-consuming culture techniques and biochemical tests, which can delay the initiation of appropriate antimicrobial therapy. MALDI-TOF MS avoids these delays by using characteristic ribosomal protein mass patterns of microbial cells, enabling accurate species-level identification within minutes.Principle...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Inhibitors of Gram-positive Cell Wall Synthesis01:23

Inhibitors of Gram-positive Cell Wall Synthesis

Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...